Clinical Trials Directory

Trials / Completed

CompletedNCT00449267

Aurolab Hydrophobic Foldable Intraocular Lens Study

Clinical Evaluation of Hydrophobic Foldable Intraocular Lenses

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Aurolab · Academic / Other
Sex
All
Age
40 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate whether hydrophobic intraocular lenses manufactured by aurolab are safe and effective in the surgical treatment of cataract.

Detailed description

Hydrophobic as the name suggests is fear for water. Hydrophobic foldable IOLs are made from acrylic material. Aurolab has developed its own hydrophobic acrylic material. This material has been subjected to several biocompatibility studies and it has proved itself to be biocompatible.

Conditions

Interventions

TypeNameDescription
DEVICEIntraocular LensPhacoemulsification with in the bag implantation of the IOL

Timeline

Start date
2007-03-01
Primary completion
2007-12-01
Completion
2007-12-01
First posted
2007-03-20
Last updated
2009-02-11

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT00449267. Inclusion in this directory is not an endorsement.

Aurolab Hydrophobic Foldable Intraocular Lens Study (NCT00449267) · Clinical Trials Directory